Press Releases

The DuPont Human Microbiome Venture announced a research partnership with The Procter & Gamble Company (P&G), focusing on the discovery and development of innovative next generation probiotics (NGPs) for human health. Over the past years, both P&G and DuPont have...

Alnylam Pharmaceuticals Inc., the leading RNA interference (RNAi) therapeutics company, and Sharp, part of UDG Healthcare, announced an agreement for the packaging of Alnylam’s approved RNAi therapeutic in European markets. In accordance with this agreement, Sharp Belgium’s Hamont-Achel site will...

Throughout the product path and changes in packaging, the solution supports requirements for traceability down to the single package level and optimizes the repackaging process for increased efficiency and safer medicine Movilitas announced that the Alter Pharma Group, a pharmaceutical...

Regeneron Pharmaceuticals, Inc. and the University of Oxford today announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY), one of the world's largest randomized clinical trials of potential COVID-19 treatments, will evaluate Regeneron's investigational anti-viral antibody cocktail, REGN-COV2. The Phase...

Roche announced U.S. FDA approval for the expanded use of CINtec® PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information...

Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, announced that the U.S. FDA has completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients and Chiesi Farmaceutici S.p.A., an international research-focused healthcare group (Chiesi Group), announced a collaboration aimed at the...